Skip to main content
Equibles

STATE STREET CORP

Position in FTRE — Fortrea Holdings Inc.

CIK 93751 BOSTON, MA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$65,844,610
+$27,134,062 QoQ
Shares Held
3,784,173
-7.9% QoQ
Ownership
3.98%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 15% Shared 0% None 85%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. FTRE ranks #102 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,844,610 3,784,173
2026-03-31 $38,710,548 4,109,400
2025-12-31 $70,913,007 4,110,899
2025-09-30 $34,278,847 4,071,122
2025-06-30 $21,894,880 4,432,162
2025-03-31 $24,637,424 3,263,235
2024-12-31 $62,871,164 3,371,108
2024-09-30 $65,013,860 3,250,693
2024-06-30 $70,419,487 3,017,116
2024-03-31 $125,991,632 3,138,805
2023-12-31 $100,444,398 2,878,063
2023-09-30 $80,129,850 2,802,723